Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at UBS Global Healthcare Conference Transcript

May 25, 2022 / 02:45PM GMT
Release Date Price: $34.21 (+0.29%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Hi, I'm John Sourbeer. I cover life sciences, diagnostic tools and pharma services at UBS. Excited for our next fireside chat. We have Maravai. And with us is Kevin Herde, CFO. Great. Welcome, Kevin.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Thanks, John.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Great. So -- and also a reminder, if anyone in the audience has any questions, you can send it through and we have the iPads up here, and we can take them as well. So I guess to start off on COVID, you provided CleanCap guidance this year, 12% to 14% growth. Any update on where this stands on what is contracted and kind of what is driving the guidance for the year?

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes, certainly, John. I mean I think the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot